CD34+ Cell Isolation from Cord Blood MNC

 CD34+ cells offer valuable insights into hematopoiesis, hematological disorders, and regenerative medicine. They have potential in cancer therapies, autoimmune diseases, and genetic disorders. Isolating CD34+ cells from Cord Blood Mononuclear Cells (MNC) is crucial for research in hematopoietic stem cell biology and therapeutic advancements. MARS® Platform ensures the enrichment of CD34+ cells, enhancing purity, viability, […]


近年来,多能造血干细胞(HSC)治疗因其一系列的具有希望的疗效已成为一种流行的技术。广泛的可能性使这种前沿治疗方法成 为现代医学的转折点。该技术面临的其中一个公认的挑战是为移植快速获得足够数量的高纯度的所需细胞类型。目前,耗时的样 品制备步骤和在此过程中大量细胞损失仍然是一个重大的挑战。MARS®平台通过一种简单的方法从激活的血液中分离CD34+细胞,而不需要RBC裂解和密度梯度离心。

High Efficiency Separation of CD34+ HSC from Mobilized Blood

In recent years multipotent haematopoietic stem cell (HSC) therapy has become a popular technique with a range of promising health benefits. A broad variety of possibilities makes this cutting-edge therapy a turning point in modern medicine. One of the recognized challenges is the ability to quickly obtain a sufficient number of desired cell types for transplantation, with […]